These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26563303)

  • 1. In Vitro Activity of Tigecycline Against Acinetobacter baumannii: Global Epidemiology and Resistance Mechanisms.
    Pournaras S; Koumaki V; Gennimata V; Kouskouni E; Tsakris A
    Adv Exp Med Biol; 2016; 897():1-14. PubMed ID: 26563303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.
    Yoon EJ; Courvalin P; Grillot-Courvalin C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2989-95. PubMed ID: 23587960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline.
    Kooli I; Brahim HB; Kilani M; Gannouni C; Aouam A; Toumi A; Loussaief C; Hattab MN; Chakroun M
    J Glob Antimicrob Resist; 2016 Jun; 5():62-3. PubMed ID: 27436468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates.
    Li H; Wang X; Zhang Y; Zhao C; Chen H; Jiang S; Zhang F; Wang H
    Future Microbiol; 2015; 10(3):337-46. PubMed ID: 25812457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii.
    Yoon EJ; Chabane YN; Goussard S; Snesrud E; Courvalin P; Dé E; Grillot-Courvalin C
    mBio; 2015 Mar; 6(2):. PubMed ID: 25805730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
    Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
    J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.
    Costello SE; Gales AC; Morfin-Otero R; Jones RN; Castanheira M
    Microb Drug Resist; 2016 Jun; 22(4):253-8. PubMed ID: 26716768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.
    Hornsey M; Ellington MJ; Doumith M; Thomas CP; Gordon NC; Wareham DW; Quinn J; Lolans K; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Aug; 65(8):1589-93. PubMed ID: 20554571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
    Yuhan Y; Ziyun Y; Yongbo Z; Fuqiang L; Qinghua Z
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):165-71. PubMed ID: 27192584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
    Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
    New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.